Larvol Delta - CHARGE-RibociclibampBelinostat-In-Patients-w-Metastatic-Triple-Neg-Breast-Cancer-amp-Recurrent-Ovarian-Cancer-w-Response-Prediction-By-Genomics

Kisqali (ribociclib) - Novartis

Beleodaq (belinostat) - Aurobindo, Assertio

http://clinicaltrials.gov/ct2/show/NCT04315233

Sep 5, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next